Aspire Biopharma Holdings, Inc. — Form 8-K
Filed September 8, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Aspire Biopharma Holdings, Inc. changed its corporate name to Aspire-Lakewood Holdings, Inc., effective upon Delaware filing on September 8, 2026. The rebranding follows the company's acquisition of Dura Control Systems Corp. (DCSC), a designer/manufacturer of automotive and industrial control systems with 11 global manufacturing facilities, 310+ patents, and tier-one OEM supplier relationships. The ticker symbol ASBP remains unchanged; no stockholder action required; the holding company structure now reflects the expanded, diversified business scope.
Why this rating
Name change and holding-company restructuring are administrative. DCSC acquisition is real but no financials disclosed; cannot measure relative impact on $17.4M market-cap company. Rebranding alone is routine.
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.